Skip to main content
. 2013 Jan 29;108(3):721–726. doi: 10.1038/bjc.2013.13

Table 1. Summary of hazard ratios by cancer site and for age band, and time to cancer diagnosis.

 
Number of cancers
Rate per 1000 person years
 
Cancer site Zoster No zoster Zoster No zoster Hazard ratio 95% CI Median time from zoster to cancer (days) (IQR)
Combined
658
1396
12.08
5.10
2.42
2.21, 2.66
815 (387, 1309)
Ovary
20
19
0.37
0.07
5.35
2.85, 10.03
962 (349, 1392)
Connective tissue
8
10
0.15
0.04
4.46
1.75, 11.40
657 (382, 1664)
Eye, brain, and other CNS
8
9
0.15
0.03
4.00
1.49, 10.75
1003 (669, 1314)
Oesophagus
24
36
0.44
0.13
3.35
2.00, 5.61
977 (557, 1331)
Oral cavity and pharynx
7
12
0.13
0.04
3.12
1.23, 7.97
925 (582, 1555)
Haematological
70
119
1.29
0.43
3.02
2.52, 4.06
713 (416, 1130)
Lung
89
159
1.63
0.58
2.90
2.23, 3.76
741 (293, 1205)
Breast
113
212
2.75
0.78
2.74
2.18, 3.44
873 (513, 1262)
Cervix and uterus
18
35
0.33
0.13
2.66
1.51, 4.70
1114 (572, 1571)
Pancreas
20
36
0.37
0.13
2.54
1.42, 4.53
1172 (591, 1484)
Prostate
84
172
1.54
0.63
2.49
1.92, 3.24
750 (368, 1330)
Renal
16
18
0.29
0.07
2.32
1.13, 4.75
1146 (705, 1582)
Unknown primary
39
93
0.72
0.34
2.15
1.48, 3.13
1051 (566, 1435)
Melanoma
17
42
0.31
0.15
2.14
1.22, 3.77
1165 (823, 1452)
Colorectal
83
226
1.52
0.83
1.87
1.45, 2.40
938 (400, 1409)
Bladder
23
86
0.42
0.31
1.37
0.86, 2.17
938 (422, 1420)
Miscellaneousa
9
63
0.17
0.23
1.27
0.68, 2.39
1094 (553, 1435)
Hepatocellular/bile duct
5
24
0.09
0.09
1.12
0.42, 2.93
1105 (827, 1400)
Stomach
5
25
0.09
0.09
1.04
0.40, 2.72
1112 (623, 1431)
Age bands for all cancer types combined (years)
 18–50 42 33 2.73 0.45 6.57 4.18, 10.41 1080 (416, 1450)
 51–60 93 175 7.86 2.94 2.72 2.12, 3.50 884 (513, 1424)
 61–70 175 309 14.50 5.08 2.92 2.43, 3.52 847 (423, 1419)
 71–80 228 591 15.05 7.41 2.07 1.77, 2.41 793 (379, 1277)
 >80 120 288 26.10 11.66 2.23 1.83, 2.81 713 (290, 1147)

Abbreviations: CI=confidence interval; CNS=central nervous system; IQR=interquartile range.

a

The miscellaneous group of cancers included very small numbers of cancers that could not be grouped elsewhere (including and described as thyroid cancer, vagina, penis, adrenal, ‘genitourinary', small intestine, maxillary sinus, pelvic peritoneum, and retroperitoneal).